Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Clinical Decision Support System (CDSS) Market (Solutions: Integrated CDSS Solutions, Standalone CDSS Solutions; Application: Clinical Guidelines, Drug Dosing Support, Clinical Reminders, Drug Allergy Alerts, Drug-Drug Interactions, Others; Model: Knowledge-based CDSS Solution, NonKnowledge-based CDSS Solution; Mode of Delivery: On-premise, Web Based, Cloud Based; Component: Hardware, Software, Service; Entity Capacity: Less than 100 Beds, 100–199 Beds, 200–299 Beds, 300–399 Beds, 400–499 Beds, More than 500 Beds) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2012-2022”, forecasts that the global market for clinical decision support system (CDSS) is anticipated to grow at a CAGR of more than 21% from 2016 to 2022 and reach the market value of over $1,500 million by 2022. Increasing need for offering remote patient monitoring services and requirement of advanced healthcare information systems to assist healthcare professionals in effective drug delivery are some major reasons driving the growth of this market, globally. Clinical decision support system is a kind of health information system designed to assist healthcare professionals, physicians, and other healthcare facilities with effective clinical decision support.
Download sample pages of this report @ https://www.acumenresearchandconsulting.com/request-sample/357
North America accounted for the largest share in clinical decision support systems market in 2015 and is expected to maintain its dominance throughout the forecast period. This segment accounted for more than 50% share and is anticipated to grow at a CAGR of over 22% during the forecast period. The growth of CDSS solutions in North America is mainly spurred by well established healthcare infrastructure, increased healthcare spending, and rising geriatric population in the region. In a report, WHO has projected the cases of lung cancer to grow from 324,000 in 2012 to 541,000 in 2030, which further creates the opportunity for players in CDSS market in North America. North America is followed by Western Europe in terms of adoption of CDSS solutions, and the region is expected to grow at a CAGR of over 20% during the forecast period.
Browse key industry insights spread across 214 pages report, “Clinical Decision Support System (CDSS) Market” in detail along with the table of contents:
Integrated solutions and standalone solutions are the two major types of CDSS solutions available. Integrated solutions segment accounted for more than 70% share in the global clinical decision support systems market in 2015 and is expected to continue dominating throughout the forecast period. This is due to the comprehensive functions offered by integrated solutions such as medication management services that helps in preventing medication errors. Integrated solutions assist in improving the quality of healthcare and patient safety and delivers better healthcare outcomes. Integrated solutions are usually installed with electronic health records (EHR) and computerized physician order entry (CPOE) systems.
Make an inquiry for purchasing this report @ https://www.acumenresearchandconsulting.com/inquiry-before-buying/357
Depending on different applications, the global CDSS market is segmented into drug-drug interaction, drug allergy alert, clinical guidelines, clinical reminders, drug dosing support, and others. The drug delivery alert segment accounted for the largest share in the global CDSS market, registering a sales value of over $135 million in 2015 and a CAGR of around 22% during the period from 2016 to 2022. Other major applications of CDSS include drug-drug interactions and clinical reminders, with both these segments together accounting for around 45% market share.
Among the players operating in the global CDSS market, some profiled in the report include Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions Inc., IBM Corporation, Relx Group Plc, Mckesson Corporation, General Electric Company, Siemens AG, Meditech, and Zynx Health Incorporated among others. Partnership expansion, strategic relationships for technology sharing and development, and acquisitions are some major strategies followed by leading players in this market to sustain market competition.
Buy this premium research report @ https://www.acumenresearchandconsulting.com/buy-now/0/357
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.